Bioidentical hormone replacement therapy for men: Science, safety, and real-world results

Most prescription testosterone replacement used in men is already “bioidentical.” The hormone molecule is chemically identical to what the testes produce, even as levels commonly decline about 1% per year after age 30 to 40. The real question is whether you have symptomatic, consistently low testosterone and how to dose and monitor therapy to restore a healthy range without overshooting.

Key takeaways

• Most FDA-approved testosterone injections, gels, and patches are already bioidentical (chemically identical to natural testosterone), so the real clinical question is whether a man has symptomatic, consistently low levels and is dosed and monitored to avoid overshooting.
• Testosterone is regulated by the hypothalamic-pituitary-gonadal axis through negative feedback: GnRH from the hypothalamus prompts LH from the pituitary, which drives testicular testosterone. Replacement testosterone can also convert to estradiol and DHT, so dose control shapes both benefits and side effects.
• Men are most likely to benefit when persistent symptoms line up with consistently low testosterone on repeat early-morning tests. Total testosterone below 300 ng/dL is a commonly used cut-off.
• A guideline-based workup includes repeat fasting early-morning total testosterone, free testosterone when total testosterone is borderline or SHBG is altered, and LH and FSH to separate primary from secondary hypogonadism. Hematocrit and PSA are checked before any testosterone therapy, and prolactin is added when LH is low or low-normal.
• Large randomized trial data have made the cardiovascular safety picture more reassuring for appropriately selected men, but safety still depends on monitoring. Testosterone and hematocrit are checked after starting therapy, prostate cancer risk is evaluated during the first year, and follow-up continues after that.

The relationship

Bioidentical hormone replacement therapy for men usually means testosterone replacement therapy using hormones that are chemically identical to the testosterone the body makes. “Bioidentical” means the molecule has the same structure as natural human testosterone. Gels, patches, and pellets deliver testosterone itself. Injectable and oral products use testosterone esters, which the body splits to release the same molecule.

Testosterone is the main male sex hormone. It supports:

• libido
• sperm production
• muscle mass
• bone density
• red blood cell production
• mood

Levels peak in early adulthood and then fall gradually. The Massachusetts Male Aging Study, reported by Feldman and colleagues in The Journal of Clinical Endocrinology & Metabolism in 2002, followed men aged 40 to 70 at baseline for 7 to 10 years.^[1] Over that time, total testosterone fell about 1.6% per year and bioavailable testosterone about 2% to 3% per year.^[1] Some men develop hypogonadism. The Endocrine Society defines it as symptoms and signs of testosterone deficiency together with unequivocally and consistently low testosterone.^[2]

Treatment aims to restore testosterone to a healthy range when a deficiency is documented and symptoms affect quality of life. According to the 2018 American Urological Association (AUA) guideline and the 2018 Endocrine Society guideline, testosterone therapy is for symptomatic men with reliably low levels.^{[3] [2]} The decision rests on careful assessment of testosterone levels, symptoms, and signs.^[3] It is not meant for “optimization” or anti-aging in men with normal levels.

How it works

How natural testosterone is made and controlled

The hypothalamic-pituitary-gonadal axis is the hormone loop that runs from the brain to the testicles. The hypothalamus releases gonadotropin-releasing hormone (GnRH). GnRH signals the pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH tells the testicles to make testosterone. FSH, together with testosterone inside the testes, supports sperm production.

When blood testosterone is high, the brain turns the signal down. When it is low, the brain turns the signal up. Testosterone taken from outside the body feeds into this same loop. It lowers LH and FSH and can suppress sperm production. For that reason, the Endocrine Society recommends against starting testosterone therapy in men who are planning fertility in the near term.^[2]

What “bioidentical” testosterone really means

Bioidentical testosterone has the same molecular structure as the natural hormone, C₁₉H₂₈O₂. Manufacturers usually start from plant sterols, which are cholesterol-like compounds found in soy or yams. They convert these in a lab into testosterone that is indistinguishable from what the body produces.

Major FDA-approved testosterone injections, gels, and patches already use this molecule. Some compounding pharmacies and clinics use “bioidentical hormone replacement therapy” mainly as a marketing term. The label does not make a product cleaner or free of side effects.

Diagnostic thresholds and who actually benefits

Testing starts with morning total testosterone, interpreted in the context of symptoms.

• According to the Endocrine Society guideline, the first test is a fasting early-morning total testosterone measured with an accurate assay, and a low result should be confirmed with a repeat test.^[2]
• Some men have total testosterone near the lower limit of normal, or a condition that alters sex hormone-binding globulin (SHBG). For them, the guideline recommends a free testosterone result, measured by equilibrium dialysis or estimated with an accurate formula.^[2]
• The AUA guideline uses total testosterone below 300 ng/dL as a reasonable cut-off, with the low result appearing on at least two early-morning measurements alongside symptoms or signs.^[3]

Once low testosterone is confirmed, both guidelines call for finding the cause. LH and FSH show whether the pattern fits primary hypogonadism or secondary/functional hypogonadism. High LH points to testicular failure. Low or inappropriately normal LH points to reduced signaling from the brain.^{[2] [3]}

The Endocrine Society recommends against starting testosterone therapy in men with any of the following:^[2]

• an elevated hematocrit
• a PSA above 4 ng/mL, or above 3 ng/mL in men at increased prostate cancer risk, without urological evaluation
• untreated severe obstructive sleep apnea
• severe lower urinary tract symptoms
• uncontrolled heart failure
• a heart attack or stroke within the past 6 months
• thrombophilia

The AUA guideline adds a prolactin test when LH is low or low-normal, because a pituitary problem can be the cause.^[3] Thyroid tests, estradiol, metabolic tests, or lipids are added when the history, exam, or other results suggest another contributor.

Delivery methods: injections, gels, patches, and pellets

When TRT is indicated, bioidentical testosterone can be delivered in several ways, each with tradeoffs.

• Injections: Testosterone cypionate or enanthate injected into muscle or fat every 1 to 2 weeks, or long-acting undecanoate every 10 to 12 weeks. With shorter-acting shots, peaks and troughs can cause swings in mood and energy.
• Gels and creams: Daily skin applications that give steadier levels. They require consistent use and care to avoid transfer to partners or children.
• Patches: Applied daily. They can cause skin irritation in some men.
• Pellets: Small implants placed under the skin every 3 to 6 months. They are convenient but harder to adjust quickly if the dose is off.

In the Testosterone Trials, published by Snyder and colleagues in The New England Journal of Medicine in 2016, 790 men aged 65 or older with total testosterone below 275 ng/dL and symptoms used testosterone gel or placebo gel for one year.^[4]

• Testosterone raised levels to the mid-normal range for young men.
• It improved sexual activity, sexual desire, and erectile function.
• It slightly improved mood and depressive symptoms but did not improve vitality.
• Walking distance did not improve within the Physical Function Trial itself.
• Adverse event rates were similar in both groups, but the trials were too small to draw conclusions about risk.

The Endocrine Society recommends aiming for mid-normal testosterone with any approved formulation.^[2] It advises choosing among formulations based on patient preference, pharmacokinetics, formulation-specific side effects, treatment burden, and cost.^[2]

What testosterone does in the body once replaced

Testosterone binds to androgen receptors inside cells in muscle, bone, brain, and sexual organs. This switches on genes that build muscle protein, increase red blood cell production, and maintain bone strength.

Some testosterone converts to estradiol, a form of estrogen that men also need in small amounts for bone health and libido. Another portion converts to dihydrotestosterone (DHT), a stronger androgen linked to prostate growth and scalp hair loss. Too high a dose can bring acne, excess red blood cells, or prostate symptoms. That is why dose, not the label “bioidentical,” determines safety.

Conditions linked to it

Low testosterone is associated with several health conditions. Some of these links are well established; others are still being studied.

• Obesity and metabolic syndrome: In population studies, low testosterone is commonly associated with type 2 diabetes and the metabolic syndrome. The relationship runs in both directions through visceral fat and muscle.^[5]
• Type 2 diabetes: In a 2011 review in The Journal of Clinical Endocrinology & Metabolism, Grossmann found that testosterone therapy in randomized trials shifted body composition modestly in a favorable direction.^[5] It did not consistently improve insulin resistance or blood sugar control. The review advised against testosterone therapy for overweight older men with type 2 diabetes and low testosterone until larger trials clarify benefits and risks.^[5]
• Osteoporosis and fractures: Testosterone supports bone formation. Men with longstanding low testosterone are at higher risk for low bone density and fractures. Replacement can increase bone mineral density over time.
• Depressed mood and low energy: Low testosterone is linked to lower mood and vitality. In the Testosterone Trials, men on testosterone reported slightly better mood and less severe depressive symptoms than men on placebo, while vitality on a fatigue scale did not improve.^[4]
• Cardiovascular disease: Low testosterone is associated with higher rates of heart disease. Lincoff and colleagues reported the TRAVERSE trial in The New England Journal of Medicine in 2023.^[6]
  • It enrolled 5,246 men aged 45 to 80 with hypogonadism and existing or high cardiovascular risk, followed for a mean of 33 months.
  • Major adverse cardiac events occurred in 7.0% of men on testosterone gel and 7.3% on placebo, meeting the trial’s noninferiority criterion.
  • Atrial fibrillation, acute kidney injury, and pulmonary embolism were more common with testosterone.
  • The Endocrine Society recommends against starting testosterone within 6 months of a heart attack or stroke, or in uncontrolled heart failure.^[2]

Many studies linking low testosterone to other diseases are observational, so they show association, not cause and effect. In Grossmann’s review, the gap in testosterone between men with and without diabetes was similar to that seen with other chronic diseases, which suggests low testosterone may partly be a marker of poor health.^[5] Longer randomized trials are needed to separate the effects of treatment from those of weight loss, better sleep, and improved overall care.

Symptoms and signals

Bioidentical hormone replacement therapy for men is not for everyone who feels tired. The strongest case for it is when classic low-testosterone symptoms line up with clearly low blood levels.

Common signals that deserve a closer look include:

• Drop in sex drive that feels out of character for you
• Weaker or less frequent morning erections
• More difficulty getting or keeping erections during sex
• Noticeable loss of muscle mass or strength despite similar workouts
• Increase in belly fat or overall body fat without major diet changes
• Lower energy or stamina through the day
• Low mood, irritability, or feeling “flat” or unmotivated
• Trouble concentrating or feeling mentally foggy
• Reduced shaving frequency or less body hair over time
• Fertility problems or low sperm counts on testing
• Fractures from minor injuries or a diagnosis of low bone density

These symptoms are not specific to low testosterone. Thyroid problems, chronic stress, poor sleep, depression, alcohol use, and many medications can cause similar issues. That is why a full evaluation matters before starting bioidentical hormone replacement therapy for men.

What to do about it

Step 1: Get properly tested

Start with a clinician who regularly manages men’s hormones, such as a urologist or endocrinologist. Describe your symptoms, lifestyle, medications, and sleep. Ask for:

• Repeat fasting early-morning total testosterone measurements, usually between 7 and 10 a.m.
• Free testosterone, by equilibrium dialysis or an accurate formula, especially when total testosterone is borderline or SHBG may be altered
• Luteinizing hormone (LH) and follicle-stimulating hormone (FSH), to identify whether the issue is primary or secondary/functional hypogonadism
• Hematocrit or a complete blood count, plus PSA if you are age 40 or older, before any testosterone therapy
• Prolactin when LH is low or low-normal
• Thyroid-stimulating hormone (TSH), estradiol, metabolic tests, or lipids when the history, exam, or labs suggest they are needed

The best candidates are men whose persistent symptoms line up with consistently low testosterone on repeat testing.^[2] LH and FSH then show whether the issue is primary or secondary/functional hypogonadism. That distinction guides whether TRT or Enclomiphene makes more sense.

Veedma offers testing that includes total and free testosterone measured by LC-MS/MS with LH and FSH, or a review of labs you already have, interpreted by licensed providers. When appropriate, treatment is Enclomiphene or a tablet combining Enclomiphene with tadalafil. Enclomiphene is not an FDA-approved drug; it is prescribed after a provider confirms the diagnosis and is compounded by a licensed U.S. pharmacy.

Step 2: Combine lifestyle changes with the right treatment choice

Lifestyle changes matter for cardiometabolic health and symptom control even when treatment is needed. The testosterone gain from them is often modest.

• Weight management: Grossmann’s review names weight loss and exercise as the first response for overweight men with type 2 diabetes and low testosterone, noting that when they succeed, they raise testosterone and bring other health benefits.^[5]
• Resistance training: 2 to 3 strength sessions per week help maintain muscle and strength.
• Sleep: Aim for 7 to 9 hours. In a 2011 JAMA study of young healthy men, Leproult and Van Cauter found that one week of sleep limited to 5 hours a night lowered daytime testosterone by 10% to 15%.^[7]
• Alcohol and drugs: Heavy drinking, anabolic steroids, and opioids can all suppress natural testosterone.

Before choosing a delivery method, classify the pattern.

• High LH with low testosterone suggests primary hypogonadism. The testes cannot respond to more signaling, and TRT is the usual treatment.
• Low or normal LH with low testosterone suggests secondary or functional hypogonadism, where the testes are intact. Options alongside TRT include treating the cause (excess weight, medications, sleep apnea) or raising the body’s own LH.
• If fertility is a goal, TRT is not appropriate because it suppresses LH, FSH, and sperm production.^[2]

Treatment options include:

• Enclomiphene: An oral medicine that blocks estrogen receptors in the hypothalamus. This raises LH and FSH so the testes make more testosterone. It is intended for secondary or functional hypogonadism and is designed to preserve sperm production and testicular size. It does not work in primary hypogonadism. Its evidence comes from smaller, shorter trials than those for testosterone.
• Testosterone cypionate injections: Usually the lowest-cost TRT option. Like all TRT, they suppress LH, FSH, and sperm production.
• Gels or creams: TRT options for men who want steadier levels and easier dose adjustments. They require daily use.
• Patches or pellets: TRT options for men who prioritize simplicity or longer dosing intervals. Pellets are harder to fine-tune quickly.

Some clinics promote compounded “custom” bioidentical creams or pellets. A pharmacy mixes these for an individual, outside standard FDA-approved products. They may be useful for a man allergic to an ingredient in commercial products. Their quality control and dose consistency are less tightly regulated. The Endocrine Society’s dosing and monitoring recommendations are written for approved formulations.^[2]

Myth vs fact

Myth: Bioidentical hormones are natural and have no side effects.

Fact: Bioidentical testosterone carries the same risks as any testosterone therapy. These include acne, a rise in red blood cells, fluid retention, and suppressed sperm production. The Endocrine Society recommends against starting testosterone in men planning fertility in the near term and calls for hematocrit monitoring during treatment.^[2] Treatments that raise the body’s own LH, such as Enclomiphene, are designed to avoid that suppression in men with secondary hypogonadism.

Myth: Only compounded pellets or creams are truly bioidentical.

Fact: Most standard injections, gels, and patches already use bioidentical testosterone and are made under FDA quality standards.

Myth: Higher testosterone is always better for health and performance.

Fact: The AUA guideline suggests aiming for total testosterone in the middle third of the normal range, 450 to 600 ng/dL.^[3] The Endocrine Society likewise targets the mid-normal range during treatment.^[2] Pushing levels higher adds risk, such as an elevated hematocrit, without clear added benefit.

Myth: Testosterone therapy always causes prostate cancer.

Fact: A 2023 prostate safety analysis of the TRAVERSE trial in JAMA Network Open studied men with hypogonadism who had been evaluated to exclude those at high prostate cancer risk.^[8] High-grade prostate cancer was rare and did not differ significantly between testosterone and placebo, although PSA rose more on testosterone.^[8] Men with prostate cancer, a palpable prostate nodule, or an unexplained elevated PSA should not start testosterone without urological evaluation. The Endocrine Society calls for evaluating prostate cancer risk during the first year of treatment.^[2]

Myth: Once you start testosterone, you can never stop.

Fact: Therapy can be tapered or stopped under supervision. Natural production often recovers, especially after shorter treatment courses, though this is not guaranteed.

Bottom line

Most approved testosterone products are already bioidentical. The label matters far less than an accurate diagnosis, realistic expectations, and long-term monitoring. In older men with symptoms and low testosterone, treatment has shown a moderate benefit for sexual function and some benefit for mood. It showed no benefit for vitality or walking distance.^[4] Measuring LH and FSH first shows whether TRT or a fertility-preserving approach fits. Sleep, weight, and exercise still matter alongside any treatment.

References

1. Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002;87:589-98. PMID: 11836290
2. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103:1715-1744. PMID: 29562364
3. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200:423-432. PMID: 29601923
4. Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of Testosterone Treatment in Older Men. N Engl J Med. 2016;374:611-24. PMID: 26886521
5. Grossmann M. Low testosterone in men with type 2 diabetes: significance and treatment. J Clin Endocrinol Metab. 2011;96:2341-53. PMID: 21646372
6. Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023;389:107-117. PMID: 37326322
7. Leproult R, Van Cauter E. Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA. 2011;305:2173-4. PMID: 21632481
8. Bhasin S, Travison TG, Pencina KM, et al. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open. 2023;6:e2348692. PMID: 38150256